Literature DB >> 25934837

Building a funded research program in cancer health disparities: considerations for young investigators.

Heather M Ochs-Balcom1, Lynette S Phillips2, Hazel B Nichols3, Elena Martinez4, Beti Thompson5, John Ojeifo6, Timothy R Rebbeck7.   

Abstract

A workshop entitled "Building a funded research program in cancer health disparities" was held at the 38th Annual American Society of Preventive Oncology (ASPO) Meeting. Organized by the Junior Members Interest Group, the session addressed topics relevant to career development for cancer disparities investigators. Such considerations include the development of research programs on a backdrop of existing multi- and transdisciplinary teams, recognizing opportunities for advancing their research, given the growth of consortia-related research, and development of effective community-based partnerships. Key strategies for developing a sustainable career in cancer health disparities in the current environment include the need to effectively engage with communities, appreciate the value of team science and develop cross-discipline collaborations, and navigate the use and utility of consortia for disparities research. Academic considerations related to earning tenure and promotion that may be faced by the junior investigator in cancer health disparities were also discussed. This report may serve to both educate and provide lessons for early-stage investigators who wish to tackle complex scientific questions while developing their careers in cancer health disparities. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2015        PMID: 25934837      PMCID: PMC4418019          DOI: 10.1158/1055-9965.EPI-15-0136

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  1 in total

1.  Challenges for multilevel health disparities research in a transdisciplinary environment.

Authors:  John H Holmes; Amy Lehman; Erinn Hade; Amy K Ferketich; Sarah Gehlert; Garth H Rauscher; Judith Abrams; Chloe E Bird
Journal:  Am J Prev Med       Date:  2008-08       Impact factor: 5.043

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.